HF1672

Summary

A Minnesota bill modifying medical cannabis provisions has been referred to the Commerce Finance and Policy Committee following a committee report. Modifications to medical cannabis rules can affect operational requirements and product access for dispensaries and patients.

More Minnesota Cannabis Bills

• SF4401Omnibus Cannabis billPassed
• SF4877Cannabis license application periods and issuance modificationIntroduced
• HF4688Cannabis license holders allowed to transport products to testing facilities.Introduced
• HF4577Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.Introduced
• SF4542Cannabis event provisions modificationIntroduced
• SF4541Cannabis business licensing provisions modificationIntroduced
• SF4519Local unit of government's cannabis business regulations provisions modificationsIntroduced
• SF4485Psilocybin therapeutic use program establishmentIntroduced
• SF4540Cannabis business license and endorsement provisions modificationIntroduced
• HF4397Cannabis business licensing provisions modified, cannabis macrobusiness license established.Introduced
• HF4398Cannabis business license and endorsement provisions modified, and civil penalties provided.Introduced
• HF4229Use of proceeds from the cannabis gross receipts tax modified, cannabis youth grant program established, and report required.Introduced